L&K Biomed엘앤케이바이오
156100 · KOSDAQ · ₩156100 · 엘앤케이바이오
₩6,270▼ ₩910 (12.67%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 16, 2026Open on DART
Predicted impact: Low
- Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)Sep 30, 2026Open on DART
- Adjustment of Conversion Price전환가액의조정Sep 9, 2026Open on DART
- Decision on Guarantee of Debt for Another Party타인에대한채무보증결정Aug 24, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 20, 2026Open on DART
- Adjustment of Conversion Price전환가액의조정Aug 19, 2026Open on DART
- Added attachment: Half-year report (Jun 2026)[첨부추가]반기보고서 (2026.06)Aug 14, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 11, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 3, 2026Open on DART
- Adjustment of Conversion Price전환가액의조정Jul 28, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jul 22, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 20, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 6, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 17, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 14, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 20, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 20, 2026Open on DART
- Audit report submitted감사보고서제출Mar 12, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Mar 12, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 12, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Feb 27, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Feb 27, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 25, 2026Open on DART
- Occurrence of Derivatives Trading Loss파생상품거래손실발생Feb 19, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 19, 2026Open on DART
- Adjustment of Conversion Price전환가액의조정Feb 9, 2026Open on DART
- Material Matters Report (Sale of Own Convertible Bonds Decision)주요사항보고서(자기전환사채매도결정)Jan 27, 2026Open on DART
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before Maturity전환사채(해외전환사채포함)발행후만기전사채취득Jan 22, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jan 19, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jan 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 14, 2026Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Jan 9, 2026Open on DART
- Exercise of Conversion Rights전환청구권행사Jan 5, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 11, 2025Open on DART
- Exercise of Conversion Rights전환청구권행사Dec 11, 2025Open on DART
- Exercise of Conversion Rights전환청구권행사Dec 3, 2025Open on DART
- Amended: Business acquisition decision[기재정정]영업양수결정(종속회사의주요경영사항)Nov 28, 2025Open on DART
- Business acquisition decision영업양수결정(종속회사의주요경영사항)Nov 27, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Nov 13, 2025Open on DART
- Exercise of Conversion Rights전환청구권행사Oct 27, 2025Open on DART
- Exercise of Conversion Rights전환청구권행사Oct 16, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 14, 2025Open on DART
- Exercise of Conversion Rights전환청구권행사Sep 8, 2025Open on DART
- Decision on Guarantee of Debt for Another Party타인에대한채무보증결정Sep 4, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Sep 1, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Exercise of Conversion Rights전환청구권행사Jul 22, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: L&K Biomed / 엘앤케이바이오 / 156100 / KRX:156100
Source: KRX statistical information